rss

Author index

May 2003, Volume 58, Issue 5

[Front cover][Table of contents]
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Ashitani, J

    • Increased concentrations of human β-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis Thorax 2003;58:425-430 doi:10.1136/thorax.58.5.425

  2. Atkins, P R

    • Inadequate peak expiratory flow meter characteristics detected by a computerised explosive decompression device Thorax 2003;58:411-416 doi:10.1136/thorax.58.5.411

B

  1. Badawi, R A

    • Exertional haemoptysis: LAM and TSC Thorax 2003;58:460 doi:10.1136/thorax.58.5.460

  2. Barak, A

    • Lung function in preschool children Thorax 2003;58:461-462 doi:10.1136/thorax.58.5.461-a

  3. Barton, S

    • Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma Thorax 2003;58:417-424 doi:10.1136/thorax.58.5.417

  4. Bastin, A J

    • Troponin T in pulmonary embolism Thorax 2003;58:416 doi:10.1136/thorax.58.5.416

  5. Beghé, B

    • Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma Thorax 2003;58:417-424 doi:10.1136/thorax.58.5.417

  6. Bhowmik, A

    • Inhaled corticosteroids and long acting β2 agonists can help patients with COPD Thorax 2003;58:424 doi:10.1136/thorax.58.5.424

  7. Boersma, W G

    • Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 2003;58:377-382 doi:10.1136/thorax.58.5.377

  8. Bos, A P

    • Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus Thorax 2003;58:383-387 doi:10.1136/thorax.58.5.383

  9. Bradshaw, L M

    • Occupational asthma evaluation
      1. Commentator:
        • P S Burge
      Thorax 2003;58:461 doi:10.1136/thorax.58.5.461

  10. Britton, J R

    • Chronic obstructive pulmonary disease • 8: Non-pharmacological management of COPD Thorax 2003;58:453-457 doi:10.1136/thorax.58.5.453

  11. Brusasco, V

    • PEF measurements Usefulness of peak expiratory flow measurements: is it just a matter of instrument accuracy? Thorax 2003;58:375-376 doi:10.1136/thorax.58.5.375
    • Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD Thorax 2006;58:399-404 doi:10.1136/thx.2005.brusascolett

  12. Buist, A S

    • Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study Thorax 2003;58:388-393 doi:10.1136/thorax.58.5.388

C

  1. Cámara, M

    • Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients Thorax 2003;58:444-446 doi:10.1136/thorax.58.5.444

  2. Chino, N

    • Increased concentrations of human β-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis Thorax 2003;58:425-430 doi:10.1136/thorax.58.5.425

  3. Clough, J B

    • Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma Thorax 2003;58:417-424 doi:10.1136/thorax.58.5.417

  4. Connolly, C K

    • Dysfunctional breathing in COPD Thorax 2003;58:460-461 doi:10.1136/thorax.58.5.460-b

  5. Cooper, S

    • Long term functional limitations in survivors of ARDS Thorax 2003;58:452 doi:10.1136/thorax.58.5.452

  6. Corris, P A

    • Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients Thorax 2003;58:444-446 doi:10.1136/thorax.58.5.444

  7. Critchley, J A

  8. Curran, A D

    • Occupational asthma evaluation
      1. Commentator:
        • P S Burge
      Thorax 2003;58:461 doi:10.1136/thorax.58.5.461

D

  1. Daykin, M

    • Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients Thorax 2003;58:444-446 doi:10.1136/thorax.58.5.444

  2. de Soyza, A

    • Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients Thorax 2003;58:444-446 doi:10.1136/thorax.58.5.444

  3. de Weerd, W

    • Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus Thorax 2003;58:383-387 doi:10.1136/thorax.58.5.383

  4. Dolmage, T E

    • Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease Thorax 2003;58:405-410 doi:10.1136/thorax.58.5.405

E

  1. Efrati, O

    • Lung function in preschool children Thorax 2003;58:461-462 doi:10.1136/thorax.58.5.461-a

  2. Enright, P L

    • Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study Thorax 2003;58:388-393 doi:10.1136/thorax.58.5.388

F

  1. Fisher, A J

    • Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients Thorax 2003;58:444-446 doi:10.1136/thorax.58.5.444

  2. Fishwick, D

    • Occupational asthma evaluation
      1. Commentator:
        • P S Burge
      Thorax 2003;58:461 doi:10.1136/thorax.58.5.461

  3. Forrest, I

    • Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients Thorax 2003;58:444-446 doi:10.1136/thorax.58.5.444

G

  1. Geddes, D M

    • Exertional haemoptysis: LAM and TSC Thorax 2003;58:460 doi:10.1136/thorax.58.5.460

  2. Goldstein, R S

    • Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease Thorax 2003;58:405-410 doi:10.1136/thorax.58.5.405

  3. Guyatt, G

    • Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease Thorax 2003;58:405-410 doi:10.1136/thorax.58.5.405

H

  1. Hardman, A

    • Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients Thorax 2003;58:444-446 doi:10.1136/thorax.58.5.444

  2. Hayward, B

    • Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma Thorax 2003;58:417-424 doi:10.1136/thorax.58.5.417

  3. Hiratsuka, T

    • Increased concentrations of human β-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis Thorax 2003;58:425-430 doi:10.1136/thorax.58.5.425

  4. Hodder, R

    • Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD Thorax 2006;58:399-404 doi:10.1136/thx.2005.brusascolett

  5. Holgate, S T

    • Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma Thorax 2003;58:417-424 doi:10.1136/thorax.58.5.417

  6. Holloway, J W

    • Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma Thorax 2003;58:417-424 doi:10.1136/thorax.58.5.417

  7. Hunter, G

    • Episodic viral wheeze in preschool children: effect of topical nasal corticosteroid prophylaxis Thorax 2003;58:431-434 doi:10.1136/thorax.58.5.431

  8. Hurst, J

    • Telephone “asthma clinics”? Thorax 2003;58:457 doi:10.1136/thorax.58.5.457

I

  1. Ihi, T

    • Increased concentrations of human β-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis Thorax 2003;58:425-430 doi:10.1136/thorax.58.5.425

  2. Iiboshi, H

    • Increased concentrations of human β-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis Thorax 2003;58:425-430 doi:10.1136/thorax.58.5.425

J

  1. Jansen, N J G

    • Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus Thorax 2003;58:383-387 doi:10.1136/thorax.58.5.383

K

  1. Karalus, N

    • Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 2003;58:377-382 doi:10.1136/thorax.58.5.377

  2. Keith, T

    • Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma Thorax 2003;58:417-424 doi:10.1136/thorax.58.5.417

  3. Keshavjee, S

    • Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease Thorax 2003;58:405-410 doi:10.1136/thorax.58.5.405

  4. Kesten, S

    • Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD Thorax 2006;58:399-404 doi:10.1136/thx.2005.brusascolett

  5. Kimpen, J L L

    • Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus Thorax 2003;58:383-387 doi:10.1136/thorax.58.5.383

  6. Kohno, S

    • Increased concentrations of human β-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis Thorax 2003;58:425-430 doi:10.1136/thorax.58.5.425

  7. Korducki, L

    • Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD Thorax 2006;58:399-404 doi:10.1136/thx.2005.brusascolett

  8. Krip, B

    • Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease Thorax 2003;58:405-410 doi:10.1136/thorax.58.5.405

L

  1. Laing, R

    • Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 2003;58:377-382 doi:10.1136/thorax.58.5.377

  2. LeBlanc, P

    • Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease Thorax 2003;58:405-410 doi:10.1136/thorax.58.5.405

  3. Lewis, S A

    • Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 2003;58:377-382 doi:10.1136/thorax.58.5.377

  4. Lim, W S

    • Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 2003;58:377-382 doi:10.1136/thorax.58.5.377

M

  1. Macfarlane, J T

    • Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 2003;58:377-382 doi:10.1136/thorax.58.5.377

  2. Maltais, F

    • Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease Thorax 2003;58:405-410 doi:10.1136/thorax.58.5.405

  3. Mannino, D M

    • Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study Thorax 2003;58:388-393 doi:10.1136/thorax.58.5.388

  4. Markhorst, D G

    • Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus Thorax 2003;58:383-387 doi:10.1136/thorax.58.5.383

  5. Meijer, P M

    • Diaphragm plication following phrenic nerve injury Thorax 2003;58:460 doi:10.1136/thorax.58.5.460-a

  6. Meinesz, A F

    • Diaphragm plication following phrenic nerve injury Thorax 2003;58:460 doi:10.1136/thorax.58.5.460-a

  7. Miller, M R

    • Inadequate peak expiratory flow meter characteristics detected by a computerised explosive decompression device Thorax 2003;58:411-416 doi:10.1136/thorax.58.5.411

  8. Minematsu, T

    • Increased concentrations of human β-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis Thorax 2003;58:425-430 doi:10.1136/thorax.58.5.425

  9. Miravitlles, M

    • Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD Thorax 2006;58:399-404 doi:10.1136/thx.2005.brusascolett

  10. Monninkhof, E

    • Self-management education for patients with chronic obstructive pulmonary disease: a systematic review Thorax 2003;58:394-398 doi:10.1136/thorax.58.5.394

  11. Morgan, M D L

    • Chronic obstructive pulmonary disease • 8: Non-pharmacological management of COPD Thorax 2003;58:453-457 doi:10.1136/thorax.58.5.453

  12. Mukae, H

    • Increased concentrations of human β-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis Thorax 2003;58:425-430 doi:10.1136/thorax.58.5.425

N

  1. Nabeshima, K

    • Increased concentrations of human β-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis Thorax 2003;58:425-430 doi:10.1136/thorax.58.5.425

  2. Nakazato, M

    • Increased concentrations of human β-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis Thorax 2003;58:425-430 doi:10.1136/thorax.58.5.425

P

  1. Pakhale, S

    • Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease Thorax 2003;58:405-410 doi:10.1136/thorax.58.5.405

  2. Partridge, M R

    • Chronic obstructive pulmonary disease Patients with COPD: do we fail them from beginning to end? Thorax 2003;58:373-375 doi:10.1136/thorax.58.5.373
    • Self-management education for patients with chronic obstructive pulmonary disease: a systematic review Thorax 2003;58:394-398 doi:10.1136/thorax.58.5.394

  3. Pedersen, O F

    • Inadequate peak expiratory flow meter characteristics detected by a computerised explosive decompression device Thorax 2003;58:411-416 doi:10.1136/thorax.58.5.411

  4. Petty, T L

    • Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study Thorax 2003;58:388-393 doi:10.1136/thorax.58.5.388

  5. Price, A

    • Lung cancer • 5: State of the art radiotherapy for lung cancer Thorax 2003;58:447-452 doi:10.1136/thorax.58.5.447

  6. Pritchard, G

    • Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients Thorax 2003;58:444-446 doi:10.1136/thorax.58.5.444

R

  1. Redd, S C

    • Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study Thorax 2003;58:388-393 doi:10.1136/thorax.58.5.388

  2. Rorke, S

    • Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma Thorax 2003;58:417-424 doi:10.1136/thorax.58.5.417

  3. Rose, E

    • Upper airways abnormalities and tracheal problems in Morquio’s disease Thorax 2003;58:458-459 doi:10.1136/thorax.58.5.458

  4. Rutherford, R

    • Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients Thorax 2003;58:444-446 doi:10.1136/thorax.58.5.444

S

  1. Sampson, A P

    • Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma Thorax 2003;58:417-424 doi:10.1136/thorax.58.5.417

  2. Sathyapala, A

    • Helical computed tomography (CT) is safe as the primary diagnostic test in suspected pulmonary embolism (PE) Thorax 2003;58:443 doi:10.1136/thorax.58.5.443

  3. Sayers, I

    • Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma Thorax 2003;58:417-424 doi:10.1136/thorax.58.5.417

  4. Silverman, M

    • Episodic viral wheeze in preschool children: effect of topical nasal corticosteroid prophylaxis Thorax 2003;58:431-434 doi:10.1136/thorax.58.5.431

T

  1. Tate, P A

    • Occupational asthma evaluation
      1. Commentator:
        • P S Burge
      Thorax 2003;58:461 doi:10.1136/thorax.58.5.461

  2. Taub, N

    • Episodic viral wheeze in preschool children: effect of topical nasal corticosteroid prophylaxis Thorax 2003;58:431-434 doi:10.1136/thorax.58.5.431

  3. Todd, T R J

    • Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease Thorax 2003;58:405-410 doi:10.1136/thorax.58.5.405

  4. Town, G I

    • Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 2003;58:377-382 doi:10.1136/thorax.58.5.377

  5. Towse, L

    • Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD Thorax 2006;58:399-404 doi:10.1136/thx.2005.brusascolett

U

  1. Unal, B

V

  1. van Aalderen, W M C

    • Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus Thorax 2003;58:383-387 doi:10.1136/thorax.58.5.383

  2. van der Eerden, M M

    • Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 2003;58:377-382 doi:10.1136/thorax.58.5.377

  3. van der Palen, J

    • Self-management education for patients with chronic obstructive pulmonary disease: a systematic review Thorax 2003;58:394-398 doi:10.1136/thorax.58.5.394

  4. van der Valk, P

    • Self-management education for patients with chronic obstructive pulmonary disease: a systematic review Thorax 2003;58:394-398 doi:10.1136/thorax.58.5.394

  5. Van Eerdewegh, P

    • Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma Thorax 2003;58:417-424 doi:10.1136/thorax.58.5.417

  6. van Gestel, J P J

    • Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus Thorax 2003;58:383-387 doi:10.1136/thorax.58.5.383

  7. van Herwaarden, C

    • Self-management education for patients with chronic obstructive pulmonary disease: a systematic review Thorax 2003;58:394-398 doi:10.1136/thorax.58.5.394

  8. van Rooy, S

    • Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease Thorax 2003;58:405-410 doi:10.1136/thorax.58.5.405

  9. van Vught, A J

    • Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus Thorax 2003;58:383-387 doi:10.1136/thorax.58.5.383

  10. van Woensel, J B M

    • Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus Thorax 2003;58:383-387 doi:10.1136/thorax.58.5.383

  11. Vilozni, D

    • Lung function in preschool children Thorax 2003;58:461-462 doi:10.1136/thorax.58.5.461-a

W

  1. Waddell, T K

    • Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease Thorax 2003;58:405-410 doi:10.1136/thorax.58.5.405

  2. Walker, P

    • Antibiotics for RTIs in adult primary care Thorax 2003;58:446 doi:10.1136/thorax.58.5.446

  3. Walker, P P

    • Upper airways abnormalities and tracheal problems in Morquio’s disease Thorax 2003;58:458-459 doi:10.1136/thorax.58.5.458

  4. Wang, M

    • Episodic viral wheeze in preschool children: effect of topical nasal corticosteroid prophylaxis Thorax 2003;58:431-434 doi:10.1136/thorax.58.5.431

  5. Ward, C

    • Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients Thorax 2003;58:444-446 doi:10.1136/thorax.58.5.444

  6. Wedzicha, Wisia

  7. Wijkstra, P J

    • Diaphragm plication following phrenic nerve injury Thorax 2003;58:460 doi:10.1136/thorax.58.5.460-a

  8. Williams, J G

    • Upper airways abnormalities and tracheal problems in Morquio’s disease Thorax 2003;58:458-459 doi:10.1136/thorax.58.5.458

  9. Williams, P

    • Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients Thorax 2003;58:444-446 doi:10.1136/thorax.58.5.444

  10. Woodhead, M

    • Community acquired pneumonia Assessment of illness severity in community acquired pneumonia: a useful new prediction tool? Thorax 2003;58:371-372 doi:10.1136/thorax.58.5.371

Y

  1. Ye, S

    • Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma Thorax 2003;58:417-424 doi:10.1136/thorax.58.5.417

Z

  1. Zielhuis, G

    • Self-management education for patients with chronic obstructive pulmonary disease: a systematic review Thorax 2003;58:394-398 doi:10.1136/thorax.58.5.394

Register for free content


Free sample
 This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
View free sample issue >>

Free archive
The full back archive is now available for Thorax. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.